A DISCRETE EVENT SIMULATION MODEL FOR RENAL CELL CARCINOMA FOR USE IN A COST-EFFECTIVENESS ANALYSIS

被引：0
作者：
Dansk, V [1 ]
Treharne, C. [2 ]
Santi, R. [2 ]
Malcolm, B. [3 ]
Johal, S. [2 ]
机构：
[1] PAREXEL, Stockholm, Sweden
[2] Parexel Int, London, England
[3] Bristol Myers Squibb, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2086
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM100
引用
收藏
页码：A748 / A748
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies
    Li, SiNi
    Li, JianHe
    Peng, LiuBao
    Li, YaMin
    Wan, XiaoMin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [42] Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma
    Hoyle, Martin
    Green, Colin
    Thompson-Coon, Jo
    Liu, Zulian
    Welch, Karen
    Moxham, Tiffany
    Stein, Ken
    VALUE IN HEALTH, 2010, 13 (01) : 61 - 68
  • [43] Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation
    Min, Serim
    Kwon, Sun-Hong
    Lee, Eui-Kyung
    Nam, Jin Hyun
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (03) : 478 - 485
  • [44] USE OF MODEL AVERAGING TECHNIQUES IN COST-EFFECTIVENESS ANALYSIS IN ONCOLOGY
    Le, H. H.
    Ozer-Stillman, I
    VALUE IN HEALTH, 2014, 17 (07) : A556 - A556
  • [45] COST-EFFECTIVENESS OF PAZOPANIB AS FIRST LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA IN BRAZIL: UPDATED ANALYSIS
    Pepe, C.
    Sedlmayer, C.
    Machado, M.
    VALUE IN HEALTH, 2013, 16 (07) : A685 - A685
  • [46] COST-EFFECTIVENESS ANALYSIS OF CURRENT TREATMENT GUIDELINES FOR WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS IN THE US (a)over-cap(sic)" A DISCRETE-EVENT SIMULATION MODEL
    Le, Q.
    Delevry, D.
    VALUE IN HEALTH, 2019, 22 : S243 - S243
  • [47] THE USE AND MISUSE OF COST-EFFECTIVENESS ANALYSIS
    GASPARI, KC
    SOCIAL SCIENCE & MEDICINE, 1983, 17 (15) : 1043 - 1046
  • [48] Cost-effectiveness of routine transoesophageal echocardiography during cardiac surgery: a discrete-event simulation study
    Dieleman, Jan M.
    Myles, Paul S.
    Bulfone, Liliana
    Younie, Sandra
    van Zaane, Bas
    McGiffin, David
    Moodie, Marj
    Gao, Lan
    BRITISH JOURNAL OF ANAESTHESIA, 2020, 124 (02) : 136 - 145
  • [49] Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis
    Fleeman, Nigel
    Houten, Rachel
    Nevitt, Sarah
    Mahon, James
    Beale, Sophie
    Boland, Angela
    Greenhalgh, Janette
    Edwards, Katherine
    Maden, Michelle
    Bhattacharyya, Devarshi
    Chaplin, Marty
    McEntee, Joanne
    Chow, Shien
    Waddell, Tom
    HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (49)
  • [50] Cost-Effectiveness of Second-Line Treatments for Metastatic Renal-Cell Carcinoma
    Giuliani, Jacopo
    Bonetti, Andrea
    CLINICAL GENITOURINARY CANCER, 2019, 17 (02) : E258 - E262
12345